Medicare Enrolled
Dr. Mary Li, M.D.
Medical Oncology · Spring Hill, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Li from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Li? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Li
Dr. Mary Li is a medical oncology in Spring Hill, FL, with 20 years in practice. Based on federal Medicare data, Dr. Li performed 270,404 Medicare services across 4,808 unique beneficiaries.
Between the years covered by Open Payments, Dr. Li received a total of $47,640 from 101 pharmaceutical and/or device companies across 1129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Li is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 7% volume in FL$ $47,640 industry payments
Medicare Practice Summary
Medicare Utilization ↗270,404
Medicare services
Top 7% in FL for medical oncology
4,808
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13,520 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 54,570 | $0 | $4 |
| Filgrastim injection (Nivestym) for white blood cells | 43,200 | $0 | $1 |
| Iron sucrose injection (Venofer) | 37,000 | $0 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 26,220 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 18,920 | $6 | $23 |
| Pembrolizumab injection (Keytruda) | 16,400 | $41 | $137 |
| Immune globulin infusion (Gammagard) | 10,950 | $36 | $108 |
| Denosumab injection (Prolia/Xgeva) | 10,620 | $18 | $51 |
| Paclitaxel chemotherapy injection | 9,618 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 9,100 | $1 | $5 |
| Dexamethasone injection (steroid) | 7,680 | $0 | $3 |
| Anti-nausea injection (ondansetron/Zofran) | 4,790 | $0 | $9 |
| Complete blood count (CBC) with differential | 3,089 | $8 | $29 |
| Blood draw (venipuncture) | 2,854 | $8 | $9 |
| Drug injection, under skin or into muscle | 1,831 | $10 | $69 |
| Office visit, established patient (30-39 min) | 1,700 | $95 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,290 | $1 | $28 |
| Injection of additional new drug or substance into vein | 1,127 | $11 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 878 | $47 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 874 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 733 | $21 | $84 |
| Injection, magnesium sulfate, per 500 mg | 702 | $1 | $2 |
| Administration of chemotherapy into vein, 1 hour or less | 598 | $97 | $378 |
| Injection, zoledronic acid, 1 mg | 554 | $7 | $69 |
| Ceftriaxone antibiotic injection | 516 | $0 | $3 |
| Infusion into a vein for hydration, each additional hour | 448 | $9 | $42 |
| Injection, diphenhydramine hcl, up to 50 mg | 441 | $1 | $3 |
| Injection, potassium chloride, per 2 meq | 440 | $0 | $4 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 349 | $15 | $56 |
| Office visit, established patient, complex (40-54 min) | 287 | $137 | $474 |
| Red blood count automated, with additional calculations | 239 | $5 | $20 |
| Injection of drug or substance into vein | 229 | $27 | $156 |
| Administration of additional new drug or substance into vein, 1 hour or less | 227 | $46 | $178 |
| Infusion, normal saline solution , 1000 cc | 220 | $2 | $7 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 210 | $1 | $7 |
| Injection, carboplatin, 50 mg | 210 | $2 | $41 |
| Office visit, established patient (20-29 min) | 203 | $64 | $239 |
| Administration of chemotherapy into vein, each additional hour | 176 | $20 | $79 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 143 | $26 | $89 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 139 | $3 | $11 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 126 | $16 | $59 |
| Automated urinalysis | 104 | $2 | $8 |
| Infusion into a vein for hydration, 31-60 minutes | 101 | $24 | $156 |
| Prothrombin time test (blood clotting) | 70 | $4 | $15 |
| New patient office visit, complex (60-74 min) | 56 | $166 | $585 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 54 | $15 | $56 |
| Administration of additional new drug or substance into vein using push technique | 36 | $42 | $170 |
| Drawing of blood for a medical problem | 31 | $62 | $277 |
| Red blood count, automated test | 23 | $4 | $10 |
| Chest X-ray, 2 views | 16 | $18 | $73 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 12 | $131 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
25.3% high complexity
71.3% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,640
Total received (2018-2024)
Avg $6,806/year across 7 years
Top 13% in FL for medical oncology
101
Companies
1,129
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,683 (43.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,241 (42.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,738 (12.0%)
Other
Charitable contributions, space rental, and other categories
$977 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$7,133
2023$5,935
2022$7,195
2021$2,018
2020$5,938
2019$9,687
2018$9,734
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$6,741
AstraZeneca Pharmaceuticals LP
$6,182
Janssen Biotech, Inc.
$4,151
Bayer HealthCare Pharmaceuticals Inc.
$4,006
AMAG Pharmaceuticals, Inc.
$3,262
Eisai Inc.
$3,150
E.R. Squibb & Sons, L.L.C.
$2,324
Novartis Pharmaceuticals Corporation
$1,540
GENZYME CORPORATION
$1,468
CTI BioPharma Corp.
$1,099
PFIZER INC.
$1,017
Genentech USA, Inc.
$915
Seagen Inc.
$798
BeiGene USA, Inc.
$751
Amgen Inc.
$535
Incyte Corporation
$489
Astellas Pharma US Inc
$415
GlaxoSmithKline, LLC.
$382
Daiichi Sankyo Inc.
$374
Merck Sharp & Dohme Corporation
$349
Gilead Sciences, Inc.
$323
Merck Sharp & Dohme LLC
$296
Pharmacyclics LLC, An AbbVie Company
$283
G1 Therapeutics, Inc.
$269
Takeda Pharmaceuticals U.S.A., Inc.
$269
ABBVIE INC.
$244
TESARO, Inc.
$235
Mirati Therapeutics, Inc.
$223
Lilly USA, LLC
$214
Kite Pharma, Inc.
$205
EISAI INC.
$190
Pharmacyclics LLC, an AbbVie Company
$186
Clovis Oncology, Inc.
$186
Aurobindo Pharma USA, Inc.
$176
Genmab U.S., Inc.
$173
Aveo Pharmaceuticals, Inc.
$163
Rigel Pharmaceuticals, Inc.
$148
Taiho Oncology, Inc.
$146
SOBI, INC
$139
EMD Serono, Inc.
$139
Janssen Pharmaceuticals, Inc
$132
Phathom Pharmaceuticals, Inc.
$130
Blueprint Medicines Corporation
$128
Ethicon Inc.
$124
PUMA BIOTECHNOLOGY, INC.
$115
Karyopharm Therapeutics Inc.
$112
Boehringer Ingelheim Pharmaceuticals, Inc.
$112
Pharmacosmos Therapeutics Inc.
$111
Octapharma USA, Inc.
$110
Regeneron Healthcare Solutions, Inc.
$108
NOVARTIS PHARMACEUTICALS CORPORATION
$105
Stemline Therapeutics Inc.
$102
CSL Behring
$101
Agios Pharmaceuticals, Inc.
$97
Bayer Healthcare Pharmaceuticals Inc.
$97
ARRAY BIOPHARMA INC
$96
Myovant Sciences Inc.
$87
Epizyme, Inc.,
$84
Puma Biotechnology, Inc.
$80
Ipsen Biopharmaceuticals, Inc
$79
SERVIER PHARMACEUTICALS LLC
$76
SANOFI-AVENTIS U.S. LLC
$73
Seattle Genetics, Inc.
$72
JAZZ PHARMACEUTICALS INC.
$72
Deciphera Pharmaceuticals Inc.
$71
AbbVie Inc.
$61
PharmaEssentia USA Corporation
$49
INSYS Therapeutics Inc
$48
AVEO Pharmaceuticals, Inc.
$48
Dova Pharmaceuticals
$44
Acceleron Pharma, Inc.
$44
Alexion Pharmaceuticals, Inc.
$43
Kyowa Kirin, Inc.
$40
GE HealthCare
$38
Dendreon Pharmaceuticals LLC
$37
Exelixis Inc.
$36
AbbVie, Inc.
$34
Alnylam Pharmaceuticals Inc.
$34
ADC Therapeutics America, Inc.
$32
Global Blood Therapeutics, Inc.
$31
TG THERAPEUTICS, INC.
$28
Acrotech Biopharma Inc.
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$28
Spectrum Pharmaceuticals Inc.
$27
Array BioPharma Inc.
$26
EUSA Pharma (US) LLC
$23
Adaptive Biotechnologies Corporation
$22
Sobi, Inc
$19
Sumitomo Pharma America, Inc.
$18
Partner Therapeutics, Inc.
$17
TAIHO ONCOLOGY, INC.
$17
Heron Therapeutics, Inc.
$16
Lantheus Medical Imaging, Inc.
$16
Lexicon Pharmaceuticals, Inc.
$16
Shire North American Group Inc
$14
Sirtex Medical Inc
$14
MEDIVATION FIELD SOLUTIONS LLC
$13
Advanced Accelerator Applications
$12
R-Pharm US LLC
$12
Veracyte, Inc.
$10
Secura Bio, Inc.
$8
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ERLEADA · EVENITY · EXKIVITY · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · Fabhalta · Farydak · Folotyn · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MOVANTIK · MYLOTARG · Monarch Platform · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · Quadramet · REBLOZYL · RYBREVANT · RYZNEUTA · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOQUEZNA · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Yescarta · ZEJULA · ZEPZELCA · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (43%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $18 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
9
Per 100K population
4.5
County median income
$63,193
Nearest hospital
SPRINGBROOK HOSPITAL
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Li is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), and high industry engagement (consulting-driven, top 13%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Li experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Li performed 54,570 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Li receive payments from pharmaceutical companies?
Yes. Dr. Li received a total of $47,640 from 101 companies across 1,129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Li's costs compare to other medical oncologys in Spring Hill?
Dr. Li's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Li) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Spring Hill
Browse medical oncologys in Spring Hill ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology